#retatrutide — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #retatrutide, aggregated by home.social.
-
The Biochemical Beauty of Retatrutide: How GLP-1s Work
#HackerNews #biochemistry #GLP1 #retatrutide #healthscience #drugdiscovery
-
The Biochemical Beauty of Retatrutide: How GLP-1s Work
#HackerNews #biochemistry #GLP1 #retatrutide #healthscience #drugdiscovery
-
The Biochemical Beauty of Retatrutide: How GLP-1s Work
#HackerNews #biochemistry #GLP1 #retatrutide #healthscience #drugdiscovery
-
Update: New Options for Weight Loss
The landscape of metabolic medicine is shifting beneath our feet. For the last few years, the conversation has been dominated by weekly injections like #Zepbound (#tirzepatide), #Wegovy (#semaglutide), #Foundayo (#orforglipron) and #retatrutide.
-
https://www.europesays.com/uk/633570/ Lilly’s triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial #BodyWeight #ClinicalTrial #EliLillyAndCompany #Health #Medication #Osteoarthritis #PhysicalFunction #retatrutide #UK #UnitedKingdom #WeightLoss #WeightManagement #WOMAC
-
https://www.europesays.com/ie/231968/ Lilly’s triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial #BodyWeight #ClinicalTrial #Éire #EliLillyAndCompany #Health #IE #Ireland #Medication #Osteoarthritis #PhysicalFunction #retatrutide #WeightLoss #WeightManagement #WOMAC
-
Seznamte se, retatrutide. Zabiják konkurence.
#^Eli Lilly's next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial
#GLP1 #Retatrutide #EliLilly -
Well this is a disturbing development, are the drugs we use what they seem?
I've seen how regulation has collapsed in America, I hope we're not following down that same Libertarian shit show? -
Wow!
Phase 2 data show 24% weight loss with triple-agonist retatrutide!
Key takeaways:
#Retatrutide, a triple-hormone agonist, was associated with 24.2% weight loss at the highest dose for people with #obesity.
The #GLP-1/#GIP/#glucagon agonist also reduced #HbA1c and body weight in type 2 #diabetes.
#lilly #mounjaro #ozempic #wegovy #weightloss
https://www.healio.com/news/endocrinology/20230626/this-raises-the-bar-phase-2-data-show-24-weight-loss-with-tripleagonist-retatrutide